Loading...
Vetoquinol S.A.
0O1O.L•LSE
Healthcare
Medical - Pharmaceuticals
£75.00
£-0.50(-0.66%)
Vetoquinol S.A. (0O1O.L) Company Profile & Overview
Explore Vetoquinol S.A.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Vetoquinol S.A. (0O1O.L) Company Profile & Overview
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, and dogs. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.
SectorHealthcare
IndustryMedical - Pharmaceuticals
CEODominique Derveaux
Contact Information
Company Facts
2,519 Employees
IPO DateMar 5, 2013
CountryFR
Actively Trading